Based on the 2018 National Institute on Aging—Alzheimer’s Association (NIA-AA) research framework, biomarkers of AD are grouped into those for Aβ (A), pathologic tau (T), and neurodegeneration or neuronal injury (N) [2]. Here, MAPT is linked to Alzheimer disease.